Best Practice & Research in Clinical Rheumatology

Papers
(The TQCC of Best Practice & Research in Clinical Rheumatology is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Hemophagocytic lymphohistiocytosis: An update on pathogenesis, diagnosis, and therapy138
Exercise and inflammation104
Role of diet in hyperuricemia and gout57
Clinical manifestations and treatment of antisynthetase syndrome56
Diffuse idiopathic skeletal hyperostosis: Etiology and clinical relevance51
The epidemiology of psoriatic arthritis: A literature review45
Global health policy in the 21st century: Challenges and opportunities to arrest the global disability burden from musculoskeletal health conditions42
Musculoskeletal health in the workplace36
Cardiac involvement in systemic sclerosis: Getting to the heart of the matter35
The interplay between neutrophils, complement, and microthrombi in COVID-1934
Systemic autoinflammatory diseases: Clinical state of the art33
Novel coronavirus disease-2019 (COVID-19) in people with rheumatic disease: Epidemiology and outcomes27
Hypertrophic osteoarthropathy27
Implementing models of care for musculoskeletal conditions in health systems to support value-based care26
Exercise therapy in patients with idiopathic inflammatory myopathies and systemic lupus erythematosus – A systematic literature review25
Managing patients using telerheumatology: Lessons from a pandemic25
Innovations to improve access to musculoskeletal care25
Risk assessment tools for osteoporosis and fractures in 202224
Allopurinol hypersensitivity: Pathogenesis and prevention23
Clinical features of psoriatic arthritis23
Current status of imaging of Sjogren's syndrome23
A comprehensive framework for navigating patient care in systemic sclerosis: A global response to the need for improving the practice of diagnostic and preventive strategies in SSc22
Primary hyperparathyroidism21
Symptomatic joint hypermobility21
Erdheim–Chester disease21
Nonpharmacological and nonsurgical approaches in OA20
Modifiable risk factors for bone health & fragility fractures20
The impact of lifestyle behaviours, physical activity and smoking on morbidity and mortality in patients with rheumatoid arthritis19
Exercise as a multi-modal disease-modifying medicine in systemic sclerosis: An introduction by The Global Fellowship on Rehabilitation and Exercise in Systemic Sclerosis (G-FoRSS)18
Multiple hereditary exostoses and enchondromatosis18
Improving musculoskeletal health for children and young people – A ‘call to action’18
Current status of MR imaging of juvenile idiopathic arthritis17
Contemporary imaging of rheumatoid arthritis: Clinical role of ultrasound and MRI16
Managing work participation for people with rheumatic and musculoskeletal diseases15
Imaging in the diagnosis and management of peripheral psoriatic arthritis15
Osteoporosis in 2022: Care gaps to screening and personalised medicine15
Imaging in large-vessel vasculitis15
Osteoporosis and Fragility Fractures: currently available pharmacological options and future directions15
Opportunistic tropical infections in immunosuppressed patients15
CNS vasculopathies: Challenging mimickers of primary angiitis of the central nervous system15
Risk factors for osteoporosis and fractures in rheumatoid arthritis14
Ultrasound imaging in paediatric rheumatology14
Long COVID and rheumatology: Clinical, diagnostic, and therapeutic implications14
The microbiome and systemic sclerosis: A review of current evidence13
Treating-to-target in rheumatology: Theory and practice13
Pathogenesis of psoriatic arthritis13
Muscle imaging in myositis: MRI, US, and PET13
Botulinum toxin in the management of primary and secondary Raynaud's phenomenon12
Urate transport in health and disease12
Treatment advances in gout12
Pathogenesis of calcium pyrophosphate deposition disease11
The global burden of fragility fractures – what are the differences, and where are the gaps11
Fatigue in inflammatory arthritis11
A practical approach to the evaluation and management of gastrointestinal symptoms in patients with systemic sclerosis11
Diagnosis, classification, and assessment in psoriatic arthritis10
Arboviruses related with chronic musculoskeletal symptoms10
Imaging in the diagnosis and management of axial spondyloarthritis in children10
The role of calcium crystals and their effect on osteoarthritis pathogenesis10
Change of the microvascularization in systemic sclerosis, a matter of air10
Uncommon compressive neuropathies of upper limbs10
Unmet needs in psoriatic arthritis10
Lower extremity entrapment neuropathies10
Employment outcomes in systemic sclerosis9
Calcium pyrophosphate deposition (CPPD) disease – Treatment options9
Treatment of rheumatic adverse events of cancer immunotherapy9
High-quality RMD rehabilitation and telehealth: Evidence and clinical practice9
Pre-RA: Can early diagnosis lead to prevention?9
0.031551122665405